Jul 16,2021

COTA and MedStar Health Partner To Drive Scientific Research and Expedite Delivery of Innovative Cancer Treatments

COTA, Inc., an oncology real-world data and analytics company, announced a new research partnership with MedStar Health. COTA will support MedStar Health in its use of real-world data to accelerate scientific discovery and improve care for cancer patients. COTA provides comprehensive oncology real-world data abstraction, curation, and analytics capabilities to leading healthcare provider organizations and life sciences companies that are caring and developing treatments for patients living with a wide range of cancers.

COLLABORATION PARTNERSHIP

#institution

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Jul 26,2021

Data Standardizations Support Collaboration Across RWD Stakeholders

Most real-world data (RWD) sets aren’t usable directly from the source. COTA believes that playing an active part in the development and adoption of data standards is essential to maximize the utility of RWD. Here are just a few examples of how the Company is advancing the maturity and uptake of standards to improve collaboration around RWD.

#rwd

View Analyst & Ambassador Comments
Go to original news
Aug 26,2021

Data MATRIX Introduces an AI-Operated Patient Survival Assessment Tool

Data MATRIX, a sole Real-World Evidence solutions provider in Russia, has presented a predictive analytics tool for estimating patient survival based on Real-World Data. An important feature of the presented tool for predictive analysis of Real-World Data is its countrywide potential, and the ability to collect and analyze data on different patient cohorts. The company's medical director, Polina Shpigotskaya, held a live demonstration of the tool's capabilities to the participants, using breast cancer patients as an example. However, the product is also suitable for other therapeutic areas.

PRODUCT

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Sep 23,2021

Carevive Introduces Carevive SMART Data™ to Highlight the Real-World Oncology Patient Experience

Carevive Systems (Carevive), the leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer, today launched Carevive SMART Data™, a dataset containing information from patients about their experience with treatment, combined with demographic and clinical data. Carevive SMART Data™ are captured as part of Carevive OPT-IN®. Carevive OPT-IN®, the Oncology Pragmatic Trial Investigator Network, enables patient experience data to be collected from real-world patients who are receiving treatment for cancer.

PRODUCT

#rwd

#platform

View Analyst & Ambassador Comments
Go to original news
Nov 09,2021

Carevive Launches Clinical Oncology Program in Collaboration with NorthShore University HealthSystem to Improve Cancer Treatment

Carevive Systems today announced that it has entered into a clinical research collaboration with NorthShore University HealthSystem to utilize Carevive’s Patient-Reported Outcomes Mobile Platform (PROmpt™) system in the collection of critical patient data. Part of Carevive OPT-IN™, a consortium of clinician investigators utilizing PROmpt™, the NorthShore partnership will capture real-world patient data that will help improve the overall patient experience during treatment. PROmpt will summarize clinical, anecdotal, and demographic information associated with patient treatment, in an effort to positively improve patient outcomes.

COLLABORATION PARTNERSHIP

#r&d

#rwd

#rpm

View Analyst & Ambassador Comments
Go to original news
Nov 01,2021

Flatiron Health Presents Research at ISPOR Europe

Flatiron Health is presenting results from its research collaboration with the National Institute for Health and Care Excellence (NICE) at Virtual ISPOR Europe 2021.

CLINICAL STUDY

#rwd

View Analyst & Ambassador Comments
Go to original news
Dec 16,2021

Study: 83% of Oncologists Believe Real-World Data Is Critical to Accelerating Cancer Research and Treatment

COTA announced insights from a study of practicing oncologists that found 83 percent of oncologists surveyed believe real-world data is critical to accelerating the development of potentially life-saving cancer drugs and treatments.

CLINICAL STUDY

#rwd

View Analyst & Ambassador Comments
Go to original news
May 28,2020

Carevive Launches OPT-IN – Building the Largest Real-World Cancer Patient Experience Database

Carevive Systems, a leading oncology-focused health technology company, announced today that it has launched the Carevive Oncology Pragmatic Trials Investigator Network (Carevive OPT-IN®). This consortium of physician-researchers is collecting Patient Experience Data using Carevive’s digital platform in the following cancer types: lung cancer, breast cancer, ovarian cancer, and multiple myeloma. Carevive OPT-IN® is a novel and unique real-world Patient Experience Database consisting of EHR-derived clinical data and longitudinal Patient-Reported Outcomes (PRO). Together, this combination presents the most comprehensive picture of real-world symptoms of disease and treatment in cancer.

PRODUCT

#rwd

#platform

View Analyst & Ambassador Comments
Go to original news
May 05,2020

OncoHealth Partners with Gateway Health to Provide Data-Driven Solution for Medical Oncology

OncoHealth is currently managing Gateway’s Medicare population for oncology prior authorization requests and will begin managing its Medicaid population later this year. This includes outpatient, anti-cancer, and supportive care drugs within both the medical and pharmacy care benefit. By combining the reviews of both the pharmacy benefit drugs with the medical benefit drugs, Gateway members are assured of a more complete assessment of their care. Providers participating in Gateway’s network can also conveniently access the OncoHealth platform through single sign-on, using the same credentials they use for the Gateway Provider Portal. In partnering with OncoHealth, Gateway will also gain access to Oncology Insights™, a real-world data analytics solution that combines clinical oncology data with Gateway’s health plan data.

COLLABORATION PARTNERSHIP

#institution

#ai/software

#rwd

View Analyst & Ambassador Comments
Go to original news
May 01,2020

Flatiron Health, Foundation Medicine and Genentech Partner to Launch Novel Prospective Lung Cancer Clinical Study

Flatiron Health, Foundation Medicine, and Genentech, a member of the Roche Group, in partnership with community and academic oncology practices, have launched the Prospective Clinico-Genomic (PCG) Study, NCT04180176. PCG is a novel, low-interventional study that will pilot the use of a technology-enabled prospective data collection platform to facilitate, streamline and simplify the execution of clinical trials for patients living with advanced lung cancer.

COLLABORATION PARTNERSHIP

#r&d

#rwd

View Analyst & Ambassador Comments
Go to original news
Subscribe to RWD